vs

Side-by-side financial comparison of Invesco (IVZ) and WEIBO Corp (WB). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.3× WEIBO Corp). WEIBO Corp runs the higher net margin — 35.7% vs -58.9%, a 94.6% gap on every dollar of revenue. Over the past eight quarters, WEIBO Corp's revenue compounded faster (22.6% CAGR vs 7.1%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Weibo Corporation is a Chinese social network company known for the microblogging website Sina Weibo. It is based in Beijing, China.

IVZ vs WB — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.3× larger
IVZ
$1.7B
$1.3B
WB
Higher net margin
WB
WB
94.6% more per $
WB
35.7%
-58.9%
IVZ
Faster 2-yr revenue CAGR
WB
WB
Annualised
WB
22.6%
7.1%
IVZ

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IVZ
IVZ
WB
WB
Revenue
$1.7B
$1.3B
Net Profit
$-995.9M
$458.3M
Gross Margin
Operating Margin
-86.2%
29.1%
Net Margin
-58.9%
35.7%
Revenue YoY
6.2%
Net Profit YoY
-575.8%
EPS (diluted)
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
WB
WB
Q4 25
$1.7B
Q3 25
$1.6B
$1.3B
Q2 25
$1.5B
$841.7M
Q1 25
$1.5B
$396.9M
Q4 24
$1.6B
Q3 24
$1.5B
$1.3B
Q2 24
$1.5B
$833.4M
Q1 24
$1.5B
$395.5M
Net Profit
IVZ
IVZ
WB
WB
Q4 25
$-995.9M
Q3 25
$356.4M
$458.3M
Q2 25
$197.4M
$234.8M
Q1 25
$171.1M
$108.1M
Q4 24
$209.3M
Q3 24
$55.0M
$297.4M
Q2 24
$132.2M
$164.6M
Q1 24
$141.5M
$51.1M
Operating Margin
IVZ
IVZ
WB
WB
Q4 25
-86.2%
Q3 25
16.5%
29.1%
Q2 25
14.1%
30.4%
Q1 25
18.1%
27.8%
Q4 24
19.6%
Q3 24
6.6%
29.0%
Q2 24
13.9%
28.2%
Q1 24
14.4%
25.2%
Net Margin
IVZ
IVZ
WB
WB
Q4 25
-58.9%
Q3 25
21.7%
35.7%
Q2 25
13.0%
27.9%
Q1 25
11.2%
27.2%
Q4 24
13.1%
Q3 24
3.6%
22.9%
Q2 24
8.9%
19.8%
Q1 24
9.6%
12.9%
EPS (diluted)
IVZ
IVZ
WB
WB
Q4 25
$-2.61
Q3 25
$0.66
Q2 25
$-0.03
Q1 25
$0.38
Q4 24
$0.46
Q3 24
$0.12
Q2 24
$0.29
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
WB
WB
Cash + ST InvestmentsLiquidity on hand
$1.0B
$1.1B
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$12.2B
$3.9B
Total Assets
$27.1B
$6.9B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
WB
WB
Q4 25
$1.0B
Q3 25
$973.1M
$1.1B
Q2 25
$922.7M
$1.2B
Q1 25
$821.7M
$1.2B
Q4 24
$986.5M
Q3 24
$1.0B
Q2 24
$878.5M
$1.9B
Q1 24
$895.7M
$2.1B
Total Debt
IVZ
IVZ
WB
WB
Q4 25
$1.8B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
Q4 24
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
Q1 24
$1.3B
Stockholders' Equity
IVZ
IVZ
WB
WB
Q4 25
$12.2B
Q3 25
$14.0B
$3.9B
Q2 25
$13.9B
$3.6B
Q1 25
$14.7B
$3.5B
Q4 24
$14.6B
Q3 24
$14.8B
Q2 24
$14.6B
$3.4B
Q1 24
$14.6B
$3.3B
Total Assets
IVZ
IVZ
WB
WB
Q4 25
$27.1B
Q3 25
$28.4B
$6.9B
Q2 25
$28.5B
$6.5B
Q1 25
$28.1B
$6.7B
Q4 24
$27.0B
Q3 24
$27.5B
Q2 24
$27.2B
$7.1B
Q1 24
$28.1B
$7.3B
Debt / Equity
IVZ
IVZ
WB
WB
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
WB
WB
Operating Cash FlowLast quarter
$455.8M
Free Cash FlowOCF − Capex
$432.2M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
WB
WB
Q4 25
$455.8M
Q3 25
$606.2M
Q2 25
$547.9M
Q1 25
$-84.6M
Q4 24
$316.9M
Q3 24
$438.4M
Q2 24
$489.1M
Q1 24
$-54.4M
Free Cash Flow
IVZ
IVZ
WB
WB
Q4 25
$432.2M
Q3 25
$586.4M
Q2 25
$530.4M
Q1 25
$-108.0M
Q4 24
$309.9M
Q3 24
$410.0M
Q2 24
$462.4M
Q1 24
$-75.4M
FCF Margin
IVZ
IVZ
WB
WB
Q4 25
25.5%
Q3 25
35.7%
Q2 25
35.0%
Q1 25
-7.1%
Q4 24
19.5%
Q3 24
27.1%
Q2 24
31.2%
Q1 24
-5.1%
Capex Intensity
IVZ
IVZ
WB
WB
Q4 25
1.4%
Q3 25
1.2%
Q2 25
1.2%
Q1 25
1.5%
Q4 24
0.4%
Q3 24
1.9%
Q2 24
1.8%
Q1 24
1.4%
Cash Conversion
IVZ
IVZ
WB
WB
Q4 25
Q3 25
1.70×
Q2 25
2.78×
Q1 25
-0.49×
Q4 24
1.51×
Q3 24
7.97×
Q2 24
3.70×
Q1 24
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

WB
WB

Income from operations$373.2M29%
Shares used in computing diluted net income per share attributable to Weibos shareholders$268.1M21%
Shares used in computing basic net income per share attributable to Weibos shareholders$238.6M19%
Value-added services$186.1M14%
Less: Income tax expenses$113.2M9%
Investment related income, net$45.0M4%
Product development$16.7M1%
General and administrative$10.6M1%
Sales and marketing$7.1M1%
Accretion to redeemable non-controlling interests$3.0M0%

Related Comparisons